Trend in anxiety disorders in the USA 1990-2003

Primary Care and Community Psychiatry

Volumn 13, Issue 1, 2008, Pages 1-7

  Skaer, Tracy L ^a   Sclar, David A ^a,b   Robison, Linda M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington Institute for Mental Illness Research and Training   (United States)

Author keywords

Anxiety; Depression; Generalized anxiety disorder; National ambulatory medical care survey; Panic disorder; Pharmacotherapy; Prevalence

Indexed keywords

EID: 68749102043     PISSN: 17468841     EISSN: None     Source Type: Journal    
DOI: 10.1080/17468840701795674     Document Type: Article

References (43)

1. Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998;34(Suppl):4-9.
2. White K. Anxiety disorders: an overview. R I Med 1992;75:241-44.
3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
4. Skaer TL, Robison LM, Sclar DA, Galin RS. Anxiety Disorders in the USA, 1990 to 1997. Trend in Complaint, Diagnosis, Use of Pharmacotherapy and Diagnosis of Comorbid Depression. Clin Drug Investig 2000;20:255-65.
5. Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK. Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med 2002;17:165-72.
6. Lépine JP. The epidemiology of anxiety disorders: prevalence, and societal costs. J Clin Psychiatry 2002;63(Suppl 14):4-8.
7. Price D, Beck A, Nimmer C, Bensen S. The treatment of anxiety disorders in a primary care HMO setting. Psychiatr Q 2000;71:31-45.
8. Keller MB. The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 2002;63(Suppl 8):11-6.
9. Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001;62(Suppl 8):4-9.
10. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427-35.
11. DuPont RL, Rice DP, Miller LS, Kaelber CT, Schatzberg AF. Economic costs of anxiety disorders. Anxiety 1996;2:167-72.
12. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder. Same genes, (partly) different environment? Arch Gen Psychiatry 1992;49:716-22.
13. Kendler KS. Major depression and generalized anxiety disorder: same genes (partly) different environments-revisited. Br J Psychiatry 1996;30(Suppl):68- 75.
14. Feighner JP. Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry 1999;60(Suppl 22):18-22.
15. Hunt C. The diagnosis and nature of generalized anxiety disorder. Curr Opin Psychiatry 2000;13:157-61.
16. Lenze EJ. Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep 2003;5:62-7.
17. Lydiard RB. An overview of generalized anxiety disorder: disease state-appropriate therapy. Clin Ther 2000;22(Suppl A):A3-19.
18. Möller HJ. Anxiety associated with comorbid depression. J Clin Psychiatry 2002;63(Suppl 14):22-6.
19. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998;34:24-8.
20. Sekula LK, DeSantis J, Gianetti V. Considerations in the management of the patient with comorbid depression and anxiety. J Am Acad Nurse Pract 2003;15:23-33.
21. Wittchen HU, Kessler RC, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand 2000;406(Suppl):14-23.
22. Kessler RC. Comorbidity of Depression and Anxiety Disorders. In: SSRIs in Depression and Anxiety. Montgomery S.A, den Boer J.A (editors). New York: John Wiley & Sons, Ltd, 1998; pp. 81-96.
23. National Center for Health Statistics. National Ambulatory Medical Care Surveys, 1990-2003. Microdata available at www.cdc.gov/nchs/about/major/ahcd/ ahcd1.htm [Last accessed 11 November 2006].
24. Bryant E, Shimizu I. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. National Center for Health Statistics, Vital Health Stat 2 1988;108:1-39.
25. US Public Health Service and Health Care Financing Administration. International Classification of Diseases, 9th Revision, Clinical Modification, Volume 1. DHHS publication no. (PHS) 89-1260. Washington: Public Health Service, 1989.
26. Schneider D, Appleton L, McLemore T. A reason for visit classification for ambulatory care. National Center for Health Statistics. Vital Health Stat 1979;2:1-63.
27. Instruction Manual: Reason for Visit Classification and Coding Manual, 1994. National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, 1995.
28. Food and Drug Administration. National Drug Code Directory, 1995 edition. Washington: Public Health Service, 1995.
29. Koch H, Campbell W. The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. National Center for Health Statistics, Vital Health Stat 1982;2:1-90.
30. Sclar DA, Robison LM, Skaer TL, Galin RS. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995. Harv Rev Psychiatry 1999;7:29-36.
31. Sclar DA, Robison LM, Skaer TL, Galin RS. Depression in diabetes mellitus: a national survey of office-based encounters 1990-1995. Diabetes Educ 1999;25:331-40.
32. Feldman SR, Fleischer AB, McConnell RC. Most common dermatologic problems identified by internists, 1990-1994. Arch Intern Med 1998;158:726-30.
33. Skaer TL, Robison LM, Sclar DA, Galin RS. Psychiatric co-morbidity and pharmacologic treatment patterns among patients presenting with insomnia: An assessment of national office-based encounters 1995-1996. Clin Drug Invest 1999;18:161-67.
34. US Census Bureau. Resident population estimates of the United States by age and sex: April 1, 1990 to November 1, 1999. Washington (DC): Population Estimates Program Population Division. Internet release date: December 23, 1999. http://www.census.gov/population/estimates/nation/intfile2-1.txt. [Last accessed 19 September 2000].
35. Population Division, US Census Bureau. Annual resident population estimates of the United States by age and sex, April 1, 2000 to July 1, 2002. Table NA-EST2002-ASRO-01. Internet release date: June 18, 2003. http://eire.census.gov/popest/data/national/tables/NC-EST2003-as.php. [Last accessed 20 February 2004].
36. Population Division, US Census Bureau. Annual estimates of the population by selected age groups and sex for the United States: April 1, 2000 to July 1, 2005 (NC-EST2005-02). Internet release date: May 10, 2006. http://www.census. gov/popest/national/asrh/NC-EST2005-sa.html. [Last accessed 18 January 2007].
37. Pigott TA. Anxiety disorders in women. Psychiatr Clin North Am 2003;26:621-72.
38. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 1999;60(Suppl 18):4-15.
39. Zerbe KJ. Anxiety disorders in women. Bull Menninger Clin 1995;59(2 Suppl A):A38-52.
40. Cameron OG, Hill EM. Women and anxiety. Psychiatr Clin North Am 1989;12:175-86.
41. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry 2000;62:829-30.
42. Kessler RC, Dernier O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslovsky AM. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005;352:2515-23.
43. Mojtabai R. Americans' attitudes toward mental health treatment seeking: 1990-2003. Psychiatr Serv 2007;58:642-51.